Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Colin Bristow's Stock Ratings
UBS Analyst
Colin Bristow is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/23/2025
Overall Average Return
-15.3%
Smart Score
Overall Average Return Percentile
18th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2025 | IMVT | Buy Now | Immunovant | $14.43 | 17.85% | Colin Bristow39% | $38 → $17 | Downgrade | Buy → Neutral | Get Alert |
| 04/14/2025 | AMGN | Buy Now | Amgen | $277.11 | 15.12% | Colin Bristow39% | $315 → $319 | Maintains | Neutral | Get Alert |
| 03/28/2025 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.00 | 298.01% | Colin Bristow39% | $6 → $4 | Maintains | Buy | Get Alert |
| 02/14/2025 | ENGN | Buy Now | enGene Holdings | $3.92 | 78.71% | Colin Bristow39% | $34 → $7 | Downgrade | Buy → Neutral | Get Alert |
| 02/05/2025 | PFE | Buy Now | Pfizer | $22.34 | 25.31% | Colin Bristow39% | $29 → $28 | Maintains | Neutral | Get Alert |
| 01/27/2025 | ALXO | Buy Now | ALX Oncology Holdings | $0.59 | 270.43% | Colin Bristow39% | $4 → $2.2 | Maintains | Buy | Get Alert |
| 01/08/2025 | PFE | Buy Now | Pfizer | $22.34 | 29.78% | Colin Bristow39% | $31 → $29 | Maintains | Neutral | Get Alert |
| 01/08/2025 | MRK | Buy Now | Merck & Co | $78.41 | 53.05% | Colin Bristow39% | $125 → $120 | Maintains | Buy | Get Alert |
| 12/03/2024 | PTCT | Buy Now | PTC Therapeutics | $50.20 | 41.43% | Colin Bristow39% | $47 → $71 | Maintains | Buy | Get Alert |
| 11/21/2024 | GILD | Buy Now | Gilead Sciences | $105.98 | -9.42% | Colin Bristow39% | $70 → $96 | Maintains | Neutral | Get Alert |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | 19.44% | Colin Bristow39% | $562 → $586 | Maintains | Buy | Get Alert |
| 10/31/2024 | AMGN | Buy Now | Amgen | $277.11 | 17.64% | Colin Bristow39% | $335 → $326 | Maintains | Neutral | Get Alert |
| 10/17/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | 14.55% | Colin Bristow39% | $477 → $562 | Maintains | Buy | Get Alert |
| 10/09/2024 | MRK | Buy Now | Merck & Co | $78.41 | 73.46% | Colin Bristow39% | $142 → $136 | Maintains | Buy | Get Alert |
| 10/03/2024 | BIIB | Buy Now | Biogen | $117.79 | 71.49% | Colin Bristow39% | $234 → $202 | Maintains | Neutral | Get Alert |
| 08/26/2024 | PTCT | Buy Now | PTC Therapeutics | $50.20 | -6.37% | Colin Bristow39% | → $47 | Upgrade | Neutral → Buy | Get Alert |
| 08/16/2024 | ALXO | Buy Now | ALX Oncology Holdings | $0.59 | 573.51% | Colin Bristow39% | $25 → $4 | Maintains | Buy | Get Alert |
| 08/15/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.00 | 497.01% | Colin Bristow39% | $14 → $6 | Maintains | Buy | Get Alert |
| 08/13/2024 | IMVT | Buy Now | Immunovant | $14.43 | 184.23% | Colin Bristow39% | $42 → $41 | Maintains | Buy | Get Alert |
| 08/09/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.69 | -40.83% | Colin Bristow39% | $56 → $16 | Maintains | Neutral | Get Alert |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $78.41 | 81.11% | Colin Bristow39% | $148 → $142 | Maintains | Buy | Get Alert |
| 07/31/2024 | PFE | Buy Now | Pfizer | $22.34 | 38.73% | Colin Bristow39% | $30 → $31 | Maintains | Neutral | Get Alert |
| 07/12/2024 | PFE | Buy Now | Pfizer | $22.34 | 34.26% | Colin Bristow39% | $28 → $30 | Maintains | Neutral | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $277.11 | 10.79% | Colin Bristow39% | $284 → $307 | Maintains | Neutral | Get Alert |
| 04/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $586.12 | 87.5% | Colin Bristow39% | $1090 → $1099 | Maintains | Buy | Get Alert |
| 04/17/2024 | AMGN | Buy Now | Amgen | $277.11 | 2.49% | Colin Bristow39% | $314 → $284 | Maintains | Neutral | Get Alert |
| 04/17/2024 | BIIB | Buy Now | Biogen | $117.79 | 81.68% | Colin Bristow39% | $250 → $214 | Maintains | Neutral | Get Alert |
| 04/17/2024 | GILD | Buy Now | Gilead Sciences | $105.98 | -29.23% | Colin Bristow39% | $81 → $75 | Maintains | Neutral | Get Alert |
| 04/17/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -5.02% | Colin Bristow39% | $498 → $466 | Maintains | Buy | Get Alert |
| 03/31/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.00 | 1293.03% | Colin Bristow39% | $15 → $14 | Maintains | Buy | Get Alert |
| 03/28/2024 | ENGN | Buy Now | enGene Holdings | $3.92 | 844.6% | Colin Bristow39% | → $37 | Initiates | → Buy | Get Alert |
| 03/01/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $7.17 | 652.61% | Colin Bristow39% | $56 → $54 | Maintains | Buy | Get Alert |
| 03/01/2024 | SRPT | Buy Now | Sarepta Therapeutics | $59.40 | 181.14% | Colin Bristow39% | $164 → $167 | Maintains | Buy | Get Alert |
| 02/21/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.69 | 136.69% | Colin Bristow39% | $144 → $64 | Downgrade | Buy → Neutral | Get Alert |
| 02/16/2024 | BIIB | Buy Now | Biogen | $117.79 | 112.24% | Colin Bristow39% | $276 → $250 | Maintains | Neutral | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $78.41 | 88.76% | Colin Bristow39% | $135 → $148 | Maintains | Buy | Get Alert |
| 01/31/2024 | PFE | Buy Now | Pfizer | $22.34 | 25.31% | Colin Bristow39% | $29 → $28 | Maintains | Neutral | Get Alert |
| 01/29/2024 | AMGN | Buy Now | Amgen | $277.11 | 13.31% | Colin Bristow39% | $315 → $314 | Maintains | Neutral | Get Alert |
| 01/25/2024 | BIIB | Buy Now | Biogen | $117.79 | 134.32% | Colin Bristow39% | $311 → $276 | Downgrade | Buy → Neutral | Get Alert |
| 01/24/2024 | BIIB | Buy Now | Biogen | $117.79 | 134.32% | Colin Bristow39% | → $276 | Downgrade | Buy → Neutral | Get Alert |
| 01/17/2024 | PFE | Buy Now | Pfizer | $22.34 | 29.78% | Colin Bristow39% | $27 → $29 | Maintains | Neutral | Get Alert |
| 12/14/2023 | PFE | Buy Now | Pfizer | $22.34 | 20.83% | Colin Bristow39% | $34 → $27 | Maintains | Neutral | Get Alert |
| 12/01/2023 | IMVT | Buy Now | Immunovant | $14.43 | 288.21% | Colin Bristow39% | $55 → $56 | Maintains | Buy | Get Alert |
| 11/02/2023 | AMGN | Buy Now | Amgen | $277.11 | -3.29% | Colin Bristow39% | $272 → $268 | Maintains | Neutral | Get Alert |
| 10/20/2023 | PFE | Buy Now | Pfizer | $22.34 | 52.16% | Colin Bristow39% | $36 → $34 | Assumes | Neutral → Neutral | Get Alert |
| 10/13/2023 | IMVT | Buy Now | Immunovant | $14.43 | 281.28% | Colin Bristow39% | $18 → $55 | Upgrade | Neutral → Buy | Get Alert |
| 10/04/2023 | ALXO | Buy Now | ALX Oncology Holdings | $0.59 | 4446.22% | Colin Bristow39% | $29 → $27 | Maintains | Buy | Get Alert |
| 07/24/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -13.58% | Colin Bristow39% | $399 → $424 | Maintains | Buy | Get Alert |
| 07/21/2023 | CCC | Buy Now | Carlyle Commodities | — | — | Colin Bristow39% | $22 → $20 | Maintains | Buy | Get Alert |
| 05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $59.40 | 191.25% | Colin Bristow39% | $160 → $173 | Maintains | Buy | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -18.67% | Colin Bristow39% | $375 → $399 | Maintains | Buy | Get Alert |
| 03/15/2023 | ALXO | Buy Now | ALX Oncology Holdings | $0.59 | 4782.98% | Colin Bristow39% | $31 → $29 | Maintains | Buy | Get Alert |
| 02/16/2023 | BIIB | Buy Now | Biogen | $117.79 | 188.65% | Colin Bristow39% | $337 → $340 | Maintains | Buy | Get Alert |
| 02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -23.57% | Colin Bristow39% | $373 → $375 | Maintains | Buy | Get Alert |
| 01/30/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -23.97% | Colin Bristow39% | $342 → $373 | Maintains | Buy | Get Alert |
| 01/26/2023 | PFE | Buy Now | Pfizer | $22.34 | 110.34% | Colin Bristow39% | $55 → $47 | Downgrade | Buy → Neutral | Get Alert |
| 12/16/2022 | SRPT | Buy Now | Sarepta Therapeutics | $59.40 | 165.99% | Colin Bristow39% | $100 → $158 | Upgrade | Neutral → Buy | Get Alert |
| 12/15/2022 | LLY | Buy Now | Eli Lilly | $825.45 | -49.12% | Colin Bristow39% | $428 → $420 | Maintains | Buy | Get Alert |
| 12/08/2022 | OMER | Buy Now | Omeros | $7.00 | -71.45% | Colin Bristow39% | $12 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 10/21/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -31.31% | Colin Bristow39% | $335 → $337 | Maintains | Buy | Get Alert |
| 10/18/2022 | PROK | Buy Now | ProKidney | $0.89 | 1920.2% | Colin Bristow39% | → $18 | Initiates | → Buy | Get Alert |
| 10/06/2022 | BIIB | Buy Now | Biogen | $117.79 | 162.33% | Colin Bristow39% | $238 → $309 | Maintains | Buy | Get Alert |
| 09/27/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $7.17 | 764.11% | Colin Bristow39% | $68 → $62 | Maintains | Buy | Get Alert |
| 09/26/2022 | IMVT | Buy Now | Immunovant | $14.43 | -65.34% | Colin Bristow39% | $7 → $5 | Downgrade | Buy → Neutral | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $176.84 | -17.44% | Colin Bristow39% | $154 → $146 | Maintains | Neutral | Get Alert |
| 07/28/2022 | BMY | Buy Now | Bristol-Myers Squibb | $48.23 | 55.52% | Colin Bristow39% | $73 → $75 | Maintains | Neutral | Get Alert |
| 07/18/2022 | MRK | Buy Now | Merck & Co | $78.41 | 24.99% | Colin Bristow39% | $76 → $98 | Maintains | Neutral | Get Alert |
| 04/27/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -34.37% | Colin Bristow39% | $325 → $322 | Maintains | Buy | Get Alert |
| 04/18/2022 | CCCC | Buy Now | C4 Therapeutics | $1.60 | 1525% | Colin Bristow39% | $64 → $26 | Maintains | Buy | Get Alert |
| 04/13/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -33.76% | Colin Bristow39% | $258 → $325 | Maintains | Buy | Get Alert |
| 02/28/2022 | ABBV | Buy Now | AbbVie | $176.84 | -16.88% | Colin Bristow39% | $129 → $147 | Downgrade | Buy → Neutral | Get Alert |
| 02/16/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.69 | 1379.29% | Colin Bristow39% | $1408 → $400 | Maintains | Buy | Get Alert |
| 12/13/2021 | MRK | Buy Now | Merck & Co | $78.41 | -3.07% | Colin Bristow39% | $98 → $76 | Downgrade | Buy → Neutral | Get Alert |
| 12/13/2021 | PFE | Buy Now | Pfizer | $22.34 | 168.52% | Colin Bristow39% | $52 → $60 | Upgrade | Neutral → Buy | Get Alert |
| 09/16/2021 | BIIB | Buy Now | Biogen | $117.79 | 275.24% | Colin Bristow39% | $475 → $442 | Maintains | Buy | Get Alert |
| 08/23/2021 | CADL | Buy Now | Candel Therapeutics | $4.78 | 88.48% | Colin Bristow39% | → $9 | Initiates | → Buy | Get Alert |
| 07/26/2021 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.00 | 2586.57% | Colin Bristow39% | → $27 | Initiates | → Buy | Get Alert |
| 06/10/2021 | BIIB | Buy Now | Biogen | $117.79 | 293.07% | Colin Bristow39% | → $463 | Upgrade | Neutral → Buy | Get Alert |
| 05/12/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -43.13% | Colin Bristow39% | $278 → $279 | Maintains | Buy | Get Alert |
| 04/06/2021 | ALXO | Buy Now | ALX Oncology Holdings | $0.59 | 16064.34% | Colin Bristow39% | → $96 | Initiates | → Buy | Get Alert |
| 02/01/2021 | OMER | Buy Now | Omeros | $7.00 | 256.89% | Colin Bristow39% | → $25 | Initiates | → Buy | Get Alert |
| 02/01/2021 | BTAI | Buy Now | BioXcel Therapeutics | $1.69 | 5757.99% | Colin Bristow39% | → $1584 | Initiates | → Buy | Get Alert |
| 02/01/2021 | MTEM | Buy Now | Molecular Templates | $0.00 | 12999900% | Colin Bristow39% | → $195 | Initiates | → Neutral | Get Alert |
| 01/11/2021 | SRPT | Buy Now | Sarepta Therapeutics | $59.40 | — | Colin Bristow39% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/20/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -41.3% | Colin Bristow39% | $287 → $288 | Maintains | Buy | Get Alert |
| 10/28/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $490.62 | -41.5% | Colin Bristow39% | → $287 | Initiates | → Buy | Get Alert |
| 10/28/2020 | SRPT | Buy Now | Sarepta Therapeutics | $59.40 | 256.9% | Colin Bristow39% | → $212 | Initiates | → Buy | Get Alert |
| 10/28/2020 | PTCT | Buy Now | PTC Therapeutics | $50.20 | 9.56% | Colin Bristow39% | → $55 | Initiates | → Neutral | Get Alert |
| 10/28/2020 | IMVT | Buy Now | Immunovant | $14.43 | 322.88% | Colin Bristow39% | → $61 | Initiates | → Buy | Get Alert |
| 10/28/2020 | GILD | Buy Now | Gilead Sciences | $105.98 | -42.44% | Colin Bristow39% | → $61 | Initiates | → Neutral | Get Alert |
| 10/28/2020 | BIIB | Buy Now | Biogen | $117.79 | 127.52% | Colin Bristow39% | → $268 | Initiates | → Neutral | Get Alert |
| 10/28/2020 | AMGN | Buy Now | Amgen | $277.11 | -16.28% | Colin Bristow39% | → $232 | Initiates | → Neutral | Get Alert |
| 07/29/2020 | PFE | Buy Now | Pfizer | $22.34 | 74.54% | Colin Bristow39% | $37 → $39 | Maintains | Neutral | Get Alert |
| 01/22/2020 | AMGN | Buy Now | Amgen | $277.11 | -14.11% | Colin Bristow39% | $194 → $238 | Maintains | Neutral | Get Alert |
| 04/29/2019 | MTEM | Buy Now | Molecular Templates | $0.00 | 11999900% | Colin Bristow39% | → $180 | Initiates | → Buy | Get Alert |
| 01/23/2019 | PFE | Buy Now | Pfizer | $22.34 | — | Colin Bristow39% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/02/2018 | BTAI | Buy Now | BioXcel Therapeutics | $1.69 | 965.09% | Colin Bristow39% | → $288 | Initiates | → Buy | Get Alert |
| 01/30/2013 | PFE | Buy Now | Pfizer | $22.34 | 38.73% | Colin Bristow39% | $29 → $31 | Maintains | Buy | Get Alert |
